priswong的个人主页 - 老虎社区

priswong

priswong

暂无个人介绍

IP属地：未知

76关注

2粉丝

0主题

0勋章

2021-06-07

Ok

"We Took Out The June 2007 Highs": Morgan Stanley's Sell Signal Just Hit An All Time High

2021-06-06

Hmm

抱歉，原内容已删除

2021-06-04

Wow

抱歉，原内容已删除

2021-06-02

Wow

Robinhood Adds 3 Directors, Boosting Board Ahead of IPO

2021-06-01

Wow

Here Are the 11 Best Performing IPOs of the Year

2021-05-31

Ooo

抱歉，原内容已删除

2021-05-30

Oo

抱歉，原内容已删除

2021-05-29

Wow

抱歉，原内容已删除

2021-05-27

Oo

Opinion: These cool, high-quality stocks are just right for this overheated, overvalued market

2021-05-25

Lnc

抱歉，原内容已删除

2021-05-24

Like

Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)

2021-05-23

Oo

抱歉，原内容已删除

2021-05-22

Oo

抱歉，原内容已删除

2021-05-10

Comment thanksss

抱歉，原内容已删除

2021-05-01

Wa

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3581817202947175","uuid":"3581817202947175","gmtCreate":1618760787270,"gmtModify":1620697588803,"name":"priswong","pinyin":"priswong","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":76,"tweetSize":15,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":114141886,"gmtCreate":1623060373445,"gmtModify":1634037393370,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114141886","repostId":"1194257742","repostType":4,"repost":{"id":"1194257742","kind":"news","pubTimestamp":1623059574,"share":"https://www.laohu8.com/m/news/1194257742?lang=&edition=full","pubTime":"2021-06-07 17:52","market":"us","language":"en","title":"\"We Took Out The June 2007 Highs\": Morgan Stanley's Sell Signal Just Hit An All Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=1194257742","media":"zerohedge","summary":"For the past several months, Morgan Stanley's fundamental analysts have been turning increasingly be","content":"<p>For the past several months, Morgan Stanley's fundamental analysts have been turning increasingly bearish on stocks, with the pessimistic sentimentplateauing earlier this weekwhen chief equity strategist Michael Wilson said that there is far too much optimism in the market, and that while earnings are slowly rising, forward PE multiples are far too high and are set to slide, with \"the de-rating about 75% to go or an approximate 15% decline in P/Es from here.\" As a result, in Wilson's view - which is rapidly emerging as the most bearish on Wall Street - \"<b>earnings revisions will not be able to offset that de-rating, leaving the overall market vulnerable to a 10-15 % correction over the next 6 months.\"</b></p>\n<p><img src=\"https://static.tigerbbs.com/f72ac2b1254473a56a44d443d5b0af2e\" tg-width=\"500\" tg-height=\"298\" referrerpolicy=\"no-referrer\">It now appears that Morgan Stanley's fundamental bearishness has spilled over into the bank's technical analyst team and as the bank's chief Euro equity Strategist Matthew Garman writes,<b>for only the fifth time in over 30 years, each of Morgan Stanley's five market timing indicators are giving a sell signal at the same time.</b></p>\n<p>Not only that, but the bank's Combined Market Timing Indicator - which has been in sell territory since March - just hit a new all time high of 1.19, surpassing the previous record high seen in June-2007, right around the time of the first great quant crash and before the market collapsed.</p>\n<p>According to Garman, the only time equities have risen after a \"Full House\" Sell Signal was in Feb 17, shortly after the Shanghai Accord kicked in to prevent a global recession. The other previous occasions where there was a \"Full House\" Sell Signal were Mar-90, May-92, Jun-07. According to MS,<b>\"in the 6M post the initial Full House Sell Signal, MSCI Europe has fallen on average 6%</b>.\"</p>\n<p><img src=\"https://static.tigerbbs.com/840d972b24ae257679bd7334982d19d8\" tg-width=\"1130\" tg-height=\"415\" referrerpolicy=\"no-referrer\">So with every in house risk indicator screaming sell, does that mean that Morgan Stanley will have the balls to tell its clients to sell? Why of course not, because in this market where stuff like the AMC, GameStop and Bed Bath squeezes force analysts to admit they no longer have any idea what's going on...</p>\n<p><img src=\"https://static.tigerbbs.com/79e9d638925af010cddcb25105f8a4b0\" tg-width=\"500\" tg-height=\"471\" referrerpolicy=\"no-referrer\">... Morgan Stanley is keeping the hope and assuming that the current period will be similar to 2017 - the only other time when a massive sell signal did not result in a market plunge.</p>\n<blockquote>\n <i>Back in 2017, we remained constructive despite the signal given i) strong EPS growth, ii) an early cycle environment, iii) EU inflows, iv) low sentiment and v) a rise in M&amp;A. Sentiment metrics may look more elevated than in 2017, but many of those factors remain in place today. While we see a trickier risk-reward for equities globally, we maintain our view that there is a compelling case for Europe to outperform global peers.</i>\n</blockquote>\n<p>Yet even Morgan Stanley is forced to admit that while Defensives may just scrape by after a record sell signal, cyclicals are about to be hammered. The next chart shows the relative performance of Cyclicals versus Defensives after a Full House Sell Signal on. As MS notes, \"perhaps unsurprisingly, given the poor performance at the market level, Cyclicals have struggled. In the 6M post the four initial Full House Sell Signals, Cyclicals have underperformed Defensives on average 12%, and this drops to -15% looking at any day</p>\n<p>when the MTIs have all said sell at the same time.\"</p>\n<p>This was true even in 2017 when equity markets rose: \"we previously cited similarities with the 2017 Full House Sell Signal as reasons to not get overly cautious on equity markets in aggregate at this moment in time. After the February-2017 Full House Sell Signal, MSCI Europe continued to rise pretty consistently through the rest of the year. However, despite strong performance from the market in aggregate, the performance of Cyclicals versus Defensives was much poorer. Between February and June 2017 Cyclicals underperformed Defensives by 6%.\"</p>\n<p><img src=\"https://static.tigerbbs.com/8dcf00cdefd33fef071981aa4a5547a7\" tg-width=\"1084\" tg-height=\"387\" referrerpolicy=\"no-referrer\">It's not just the bank's sell signal that is prompting concerns about the future returns of cyclicals: Borrowing a page from our own warnings (see \"China's Credit Impulse Just Turned Negative, Unleashing Global Deflationary Shockwave\"), Morgan Stanley looks at \"a number of China data points which are giving warning signs\" first and foremost the collapse in China's credit impulse, to wit:</p>\n<p>While credit tightening has been front-loaded in 1H21, as outlined here, our economists remain constructive on China's growth recovery. Having said that, a number of Chinese data points do suggest the Cyclical bounce looks overextended.<b>China's credit impulse has just turned negative, and historically this has provided a lead indicator for the year-on-year performance of European Cyclicals (Exhibit 5).</b>Similarly, the relative performance of Cyclicals versus Defensives has closely tracked moves in Chinese 10Y bond yields, which are now at their lowest levels since September 2020, standing in sharp contrast to the performance of Cyclicals.</p>\n<p><img src=\"https://static.tigerbbs.com/c85032415626480364933f91dda387bf\" tg-width=\"1065\" tg-height=\"409\"></p>\n<p>Putting it all together, readers have to ask themselves if what is coming will be an analog of the one and only episode on history when the market did not plunge after all Morgan Stanley market timing indicators hit a sell (and were at an all time high), or will this case be similar to Mar-90, May-92, Jun-07 when the outcome was anything but a happy ending.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>\"We Took Out The June 2007 Highs\": Morgan Stanley's Sell Signal Just Hit An All Time High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n\"We Took Out The June 2007 Highs\": Morgan Stanley's Sell Signal Just Hit An All Time High\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 17:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/we-took-out-june-2007-highs-morgan-stanleys-sell-signal-just-hit-all-time-high><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For the past several months, Morgan Stanley's fundamental analysts have been turning increasingly bearish on stocks, with the pessimistic sentimentplateauing earlier this weekwhen chief equity ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/we-took-out-june-2007-highs-morgan-stanleys-sell-signal-just-hit-all-time-high\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index","SPY":"标普500ETF"},"source_url":"https://www.zerohedge.com/markets/we-took-out-june-2007-highs-morgan-stanleys-sell-signal-just-hit-all-time-high","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194257742","content_text":"For the past several months, Morgan Stanley's fundamental analysts have been turning increasingly bearish on stocks, with the pessimistic sentimentplateauing earlier this weekwhen chief equity strategist Michael Wilson said that there is far too much optimism in the market, and that while earnings are slowly rising, forward PE multiples are far too high and are set to slide, with \"the de-rating about 75% to go or an approximate 15% decline in P/Es from here.\" As a result, in Wilson's view - which is rapidly emerging as the most bearish on Wall Street - \"earnings revisions will not be able to offset that de-rating, leaving the overall market vulnerable to a 10-15 % correction over the next 6 months.\"\nIt now appears that Morgan Stanley's fundamental bearishness has spilled over into the bank's technical analyst team and as the bank's chief Euro equity Strategist Matthew Garman writes,for only the fifth time in over 30 years, each of Morgan Stanley's five market timing indicators are giving a sell signal at the same time.\nNot only that, but the bank's Combined Market Timing Indicator - which has been in sell territory since March - just hit a new all time high of 1.19, surpassing the previous record high seen in June-2007, right around the time of the first great quant crash and before the market collapsed.\nAccording to Garman, the only time equities have risen after a \"Full House\" Sell Signal was in Feb 17, shortly after the Shanghai Accord kicked in to prevent a global recession. The other previous occasions where there was a \"Full House\" Sell Signal were Mar-90, May-92, Jun-07. According to MS,\"in the 6M post the initial Full House Sell Signal, MSCI Europe has fallen on average 6%.\"\nSo with every in house risk indicator screaming sell, does that mean that Morgan Stanley will have the balls to tell its clients to sell? Why of course not, because in this market where stuff like the AMC, GameStop and Bed Bath squeezes force analysts to admit they no longer have any idea what's going on...\n... Morgan Stanley is keeping the hope and assuming that the current period will be similar to 2017 - the only other time when a massive sell signal did not result in a market plunge.\n\nBack in 2017, we remained constructive despite the signal given i) strong EPS growth, ii) an early cycle environment, iii) EU inflows, iv) low sentiment and v) a rise in M&A. Sentiment metrics may look more elevated than in 2017, but many of those factors remain in place today. While we see a trickier risk-reward for equities globally, we maintain our view that there is a compelling case for Europe to outperform global peers.\n\nYet even Morgan Stanley is forced to admit that while Defensives may just scrape by after a record sell signal, cyclicals are about to be hammered. The next chart shows the relative performance of Cyclicals versus Defensives after a Full House Sell Signal on. As MS notes, \"perhaps unsurprisingly, given the poor performance at the market level, Cyclicals have struggled. In the 6M post the four initial Full House Sell Signals, Cyclicals have underperformed Defensives on average 12%, and this drops to -15% looking at any day\nwhen the MTIs have all said sell at the same time.\"\nThis was true even in 2017 when equity markets rose: \"we previously cited similarities with the 2017 Full House Sell Signal as reasons to not get overly cautious on equity markets in aggregate at this moment in time. After the February-2017 Full House Sell Signal, MSCI Europe continued to rise pretty consistently through the rest of the year. However, despite strong performance from the market in aggregate, the performance of Cyclicals versus Defensives was much poorer. Between February and June 2017 Cyclicals underperformed Defensives by 6%.\"\nIt's not just the bank's sell signal that is prompting concerns about the future returns of cyclicals: Borrowing a page from our own warnings (see \"China's Credit Impulse Just Turned Negative, Unleashing Global Deflationary Shockwave\"), Morgan Stanley looks at \"a number of China data points which are giving warning signs\" first and foremost the collapse in China's credit impulse, to wit:\nWhile credit tightening has been front-loaded in 1H21, as outlined here, our economists remain constructive on China's growth recovery. Having said that, a number of Chinese data points do suggest the Cyclical bounce looks overextended.China's credit impulse has just turned negative, and historically this has provided a lead indicator for the year-on-year performance of European Cyclicals (Exhibit 5).Similarly, the relative performance of Cyclicals versus Defensives has closely tracked moves in Chinese 10Y bond yields, which are now at their lowest levels since September 2020, standing in sharp contrast to the performance of Cyclicals.\n\nPutting it all together, readers have to ask themselves if what is coming will be an analog of the one and only episode on history when the market did not plunge after all Morgan Stanley market timing indicators hit a sell (and were at an all time high), or will this case be similar to Mar-90, May-92, Jun-07 when the outcome was anything but a happy ending.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":1602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115169754,"gmtCreate":1622959557178,"gmtModify":1634096556867,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/115169754","repostId":"1102972710","repostType":4,"isVote":1,"tweetType":1,"viewCount":941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116958887,"gmtCreate":1622771076449,"gmtModify":1634098181507,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/116958887","repostId":"1110094207","repostType":4,"isVote":1,"tweetType":1,"viewCount":1118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113805570,"gmtCreate":1622600962990,"gmtModify":1634100038118,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/113805570","repostId":"1188302386","repostType":4,"repost":{"id":"1188302386","kind":"news","pubTimestamp":1622598317,"share":"https://www.laohu8.com/m/news/1188302386?lang=&edition=full","pubTime":"2021-06-02 09:45","market":"hk","language":"en","title":"Robinhood Adds 3 Directors, Boosting Board Ahead of IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1188302386","media":"Barron's","summary":"Robinhood, on the cusp of going public, is now adding board members who can make the case that the u","content":"<p>Robinhood, on the cusp of going public, is now adding board members who can make the case that the upstart broker is ready to take a central place in the investment universe.</p>\n<p>The zero-commission investment app announced on Tuesday that it was adding three independent board members. Jon Rubinstein, a senior advisor at asset management firm PDT Partners who is a former <a href=\"https://laohu8.com/S/AAPL\">Apple</a> executive and the lead independent director at<a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a>(ticker: AMZN), adds mainstream tech experience. Paula Loop, a partner at PwC, has experience in governance, accounting, and Securities and Exchange Commission compliance. And Robert Zoellick, a fellow at Harvard University, is a former president of the World Bank and U.S. Trade Representative. That brings Robinhood’s board to seven members, two of whom are co-founders Vlad Tenev and Baiju Bhatt. The company declined to make any directors available for interviews.</p>\n<p>After disrupting the traditional brokerage industry, Robinhood is expected to go public as soon as this month. Itconfidentially filed paperswith the SEC in March. Some analysts think the company could fetch a valuation of $40 billion. Adding directors with strong reputations will likely help Robinhood’s case, although those directors are now tying their reputations to a company that has attracted considerable negative attention as well.</p>\n<p>Robinhood has walked a fine line over the past year, portraying itself to customers as a threat to the establishment. The founders have said they were inspired by the Occupy Wall Street movement to fight the power of big banks and brokers. At the same time, the company has sold itself to regulators as a responsible operator ready to take an even bigger role in the country’s financial infrastructure.</p>\n<p>Since the start of the pandemic, Robinhood has had to answer for a variety of irregularities, includingtrading outages last March, anda ban on purchases of certain stocksat the height of the<a href=\"https://laohu8.com/S/GME\">GameStop</a>(GME) frenzy in January. Massachusetts’ top securities regulator hassued the companyon allegations that it encourages risky trading for its own profit, a charge the company denies. Robinhood’s challenge will be to maintain its rebellious reputation, while also convincing regulators and customers that it is a responsible steward of their money.</p>\n<p>The next few weeks will determine how well it can make its pitch on Wall Street.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Robinhood Adds 3 Directors, Boosting Board Ahead of IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRobinhood Adds 3 Directors, Boosting Board Ahead of IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 09:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/robinhood-adds-3-directors-boosting-board-ahead-of-ipo-51622574302?mod=hp_LEAD_2><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Robinhood, on the cusp of going public, is now adding board members who can make the case that the upstart broker is ready to take a central place in the investment universe.\nThe zero-commission ...</p>\n\n<a href=\"https://www.barrons.com/articles/robinhood-adds-3-directors-boosting-board-ahead-of-ipo-51622574302?mod=hp_LEAD_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/robinhood-adds-3-directors-boosting-board-ahead-of-ipo-51622574302?mod=hp_LEAD_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188302386","content_text":"Robinhood, on the cusp of going public, is now adding board members who can make the case that the upstart broker is ready to take a central place in the investment universe.\nThe zero-commission investment app announced on Tuesday that it was adding three independent board members. Jon Rubinstein, a senior advisor at asset management firm PDT Partners who is a former Apple executive and the lead independent director atAmazon.com(ticker: AMZN), adds mainstream tech experience. Paula Loop, a partner at PwC, has experience in governance, accounting, and Securities and Exchange Commission compliance. And Robert Zoellick, a fellow at Harvard University, is a former president of the World Bank and U.S. Trade Representative. That brings Robinhood’s board to seven members, two of whom are co-founders Vlad Tenev and Baiju Bhatt. The company declined to make any directors available for interviews.\nAfter disrupting the traditional brokerage industry, Robinhood is expected to go public as soon as this month. Itconfidentially filed paperswith the SEC in March. Some analysts think the company could fetch a valuation of $40 billion. Adding directors with strong reputations will likely help Robinhood’s case, although those directors are now tying their reputations to a company that has attracted considerable negative attention as well.\nRobinhood has walked a fine line over the past year, portraying itself to customers as a threat to the establishment. The founders have said they were inspired by the Occupy Wall Street movement to fight the power of big banks and brokers. At the same time, the company has sold itself to regulators as a responsible operator ready to take an even bigger role in the country’s financial infrastructure.\nSince the start of the pandemic, Robinhood has had to answer for a variety of irregularities, includingtrading outages last March, anda ban on purchases of certain stocksat the height of theGameStop(GME) frenzy in January. Massachusetts’ top securities regulator hassued the companyon allegations that it encourages risky trading for its own profit, a charge the company denies. Robinhood’s challenge will be to maintain its rebellious reputation, while also convincing regulators and customers that it is a responsible steward of their money.\nThe next few weeks will determine how well it can make its pitch on Wall Street.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119112024,"gmtCreate":1622526473668,"gmtModify":1634100797230,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/119112024","repostId":"1105273964","repostType":4,"repost":{"id":"1105273964","kind":"news","pubTimestamp":1622511256,"share":"https://www.laohu8.com/m/news/1105273964?lang=&edition=full","pubTime":"2021-06-01 09:34","market":"hk","language":"en","title":"Here Are the 11 Best Performing IPOs of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1105273964","media":"Barron's","summary":"The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.That left us with 11 names. First up:CureVac, which was the screen’s best-performing IPO and had a total return of 596.75%. CureVac specializes in the messenger RNA, or mRNA, technology that is the basis of several leading Covid-19 vaccine programs. The German biotech company went public inAugust at $16 a shareand soared 249% in its ","content":"<p>The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.</p><p>But not everyone receives these types of opportunities. Most retail investors have to wait until companies start publicly trading to buy stock.<i>Barron’s</i>looked at businesses that have gone public in the past 12 months to find some strong performers.</p><p>First, we searched for companies that listed via a traditional initial public offering: This meant we filtered out businesses that merged withspecial purpose acquisition companies, or SPACs. Then, we searched for companies that went public on either the New York Stock Exchange or the Nasdaq. We also focused on entities that had at least a $1 billion market capitalization. We narrowed our search to companies with the highesttotal returns from their stock offering prices..</p><p>That left us with 11 names. First up:CureVac(ticker: CVAC), which was the screen’s best-performing IPO and had a total return of 596.75%. CureVac specializes in the messenger RNA, or mRNA, technology that is the basis of several leading Covid-19 vaccine programs. The German biotech company went public inAugust at $16 a shareand soared 249% in its first day, with the stock closing at $55.90. In January, CureVacstruck a deal with Bayerto accelerate the development and supply of its Covid-19 vaccine candidate. The company’s mRNA-based Covid-19 vaccine is now in clinical trials, and Phase2b/3 data is expected this summer. Since its IPO, the stock has nearly doubled, closingFriday at $111.48 .</p><p>Strong performances need not be dictated by success on the first day of trading. Four of the companies that made our list were busted deals—meaning that their shares fell below their IPO prices on the first day of trading.</p><p>Case in point:ZIM Integrated Shipping(ZIM). The asset-light shipping company went public in January with a $15 offering price,but closed that day at $11.50. Yet by May 19, ZIM’s stockhad gained 295%after itreported first-quarter earnings of $589.6 million, or $5.35 a share. The companyalso declared a special cash dividend of $2 a share. ZIM is the second-best-performing IPO in the past 12 months, based on a total return of 209.33%, according to FactSet. It closed on Friday at $46.40.</p><p>Another example isAcademy Sports &amp; Outdoors(ASO): The companywent public in Octoberwith a $13 offering price, with the stock closing at $12.99 during its first day of public trading<b>.</b>Academy was profitable when it went public, a rarity in the IPO market. InMarch, the company reported that its net incomesoared 416%, to $91.5 million, or 97 cents a share, for its fourth fiscal quarter ended Jan. 30. Its shares have nearly tripled since the IPO, and were trading at $36.53 on Friday. Academy Sports ranks third with a total return from the offering price of 181%, FactSet said.</p><p>Strong GainersThese companies all went public in the last year and produced high total returns compared to their IPO prices.<img src=\"https://static.tigerbbs.com/9dedc209ede147958c015d3a586bb587\" tg-width=\"630\" tg-height=\"606\">Rounding out this category areCorsair Gaming(CRSR), a California companythat makes performance gear for gamers, and the Dubai-basedYalla Group(YALA), whichmakes a voice-chat app usedin the Middle East and North Africa called Yalla. Both stocks have rebounded strongly after less-than-stellar September IPOs.</p><p>Some companies that made our list soared during their debuts, but have since seen their shares retreat. Still, these companies are producing gains.</p><p>ConsiderBigCommerce(BIGC), which provides a cloud e-commerce platform that is used by such customers as SkullCandy, Savannah Bee Co, and the Cleveland Cavaliers.BigCommerce&nbsp;went public in Augustwith a $24 offering price—and the stock soared 201% that day,closing at $72.27. Since the IPO, the shares have fallen nearly 25%, amid a broader technology selloff.</p><p>The company, however, has reported some positive developments, like a deal in February that wouldgive BigCommerce customersthe ability to sell directly on Walmart Marketplace. It also reported better-than-expected fourth-quarter results. BigCommerce has produced a total return of nearly 127%, according to FactSet.</p><p>Other companies have seen their shares jump since going public.Dream Finders Homes (DFH), which designs, builds, and sells homes in high-growth markets, was already profitable when it made its trading debut in January at $13 a share. Shares soared 61%, $20.95 on its first day.Prices for houses in Marchgrew at the fastest rate since 2005, which has helped real estate stocks. Dream Finders stock has gained nearly 52% since its IPO, trading Friday at $31.77. Dream Finders notched a total return from offering price of 144.38%.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here Are the 11 Best Performing IPOs of the Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere Are the 11 Best Performing IPOs of the Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-01 09:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/here-are-the-11-best-performing-ipos-of-the-year-51622472529?mod=hp_DAY_0><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.But not everyone receives these ...</p>\n\n<a href=\"https://www.barrons.com/articles/here-are-the-11-best-performing-ipos-of-the-year-51622472529?mod=hp_DAY_0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/here-are-the-11-best-performing-ipos-of-the-year-51622472529?mod=hp_DAY_0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105273964","content_text":"The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.But not everyone receives these types of opportunities. Most retail investors have to wait until companies start publicly trading to buy stock.Barron’slooked at businesses that have gone public in the past 12 months to find some strong performers.First, we searched for companies that listed via a traditional initial public offering: This meant we filtered out businesses that merged withspecial purpose acquisition companies, or SPACs. Then, we searched for companies that went public on either the New York Stock Exchange or the Nasdaq. We also focused on entities that had at least a $1 billion market capitalization. We narrowed our search to companies with the highesttotal returns from their stock offering prices..That left us with 11 names. First up:CureVac(ticker: CVAC), which was the screen’s best-performing IPO and had a total return of 596.75%. CureVac specializes in the messenger RNA, or mRNA, technology that is the basis of several leading Covid-19 vaccine programs. The German biotech company went public inAugust at $16 a shareand soared 249% in its first day, with the stock closing at $55.90. In January, CureVacstruck a deal with Bayerto accelerate the development and supply of its Covid-19 vaccine candidate. The company’s mRNA-based Covid-19 vaccine is now in clinical trials, and Phase2b/3 data is expected this summer. Since its IPO, the stock has nearly doubled, closingFriday at $111.48 .Strong performances need not be dictated by success on the first day of trading. Four of the companies that made our list were busted deals—meaning that their shares fell below their IPO prices on the first day of trading.Case in point:ZIM Integrated Shipping(ZIM). The asset-light shipping company went public in January with a $15 offering price,but closed that day at $11.50. Yet by May 19, ZIM’s stockhad gained 295%after itreported first-quarter earnings of $589.6 million, or $5.35 a share. The companyalso declared a special cash dividend of $2 a share. ZIM is the second-best-performing IPO in the past 12 months, based on a total return of 209.33%, according to FactSet. It closed on Friday at $46.40.Another example isAcademy Sports & Outdoors(ASO): The companywent public in Octoberwith a $13 offering price, with the stock closing at $12.99 during its first day of public trading.Academy was profitable when it went public, a rarity in the IPO market. InMarch, the company reported that its net incomesoared 416%, to $91.5 million, or 97 cents a share, for its fourth fiscal quarter ended Jan. 30. Its shares have nearly tripled since the IPO, and were trading at $36.53 on Friday. Academy Sports ranks third with a total return from the offering price of 181%, FactSet said.Strong GainersThese companies all went public in the last year and produced high total returns compared to their IPO prices.Rounding out this category areCorsair Gaming(CRSR), a California companythat makes performance gear for gamers, and the Dubai-basedYalla Group(YALA), whichmakes a voice-chat app usedin the Middle East and North Africa called Yalla. Both stocks have rebounded strongly after less-than-stellar September IPOs.Some companies that made our list soared during their debuts, but have since seen their shares retreat. Still, these companies are producing gains.ConsiderBigCommerce(BIGC), which provides a cloud e-commerce platform that is used by such customers as SkullCandy, Savannah Bee Co, and the Cleveland Cavaliers.BigCommerce went public in Augustwith a $24 offering price—and the stock soared 201% that day,closing at $72.27. Since the IPO, the shares have fallen nearly 25%, amid a broader technology selloff.The company, however, has reported some positive developments, like a deal in February that wouldgive BigCommerce customersthe ability to sell directly on Walmart Marketplace. It also reported better-than-expected fourth-quarter results. BigCommerce has produced a total return of nearly 127%, according to FactSet.Other companies have seen their shares jump since going public.Dream Finders Homes (DFH), which designs, builds, and sells homes in high-growth markets, was already profitable when it made its trading debut in January at $13 a share. Shares soared 61%, $20.95 on its first day.Prices for houses in Marchgrew at the fastest rate since 2005, which has helped real estate stocks. Dream Finders stock has gained nearly 52% since its IPO, trading Friday at $31.77. Dream Finders notched a total return from offering price of 144.38%.","news_type":1,"symbols_score_info":{"BOTB.UK":0.9}},"isVote":1,"tweetType":1,"viewCount":1300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":110805166,"gmtCreate":1622435620155,"gmtModify":1634101483775,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/110805166","repostId":"2139487733","repostType":4,"isVote":1,"tweetType":1,"viewCount":1326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137735309,"gmtCreate":1622389345301,"gmtModify":1634101875427,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/137735309","repostId":"2138107131","repostType":4,"isVote":1,"tweetType":1,"viewCount":1173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137970181,"gmtCreate":1622292004043,"gmtModify":1634102486086,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/137970181","repostId":"2138948877","repostType":4,"isVote":1,"tweetType":1,"viewCount":1281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":132283629,"gmtCreate":1622091529161,"gmtModify":1634183908138,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/132283629","repostId":"1193634953","repostType":4,"repost":{"id":"1193634953","kind":"news","pubTimestamp":1622087134,"share":"https://www.laohu8.com/m/news/1193634953?lang=&edition=full","pubTime":"2021-05-27 11:45","market":"us","language":"en","title":"Opinion: These cool, high-quality stocks are just right for this overheated, overvalued market","url":"https://stock-news.laohu8.com/highlight/detail?id=1193634953","media":"MarketWatch","summary":"Well-managed companies boast strong cash flow, a stable shareholder base, and are under most investo","content":"<blockquote><b>Well-managed companies boast strong cash flow, a stable shareholder base, and are under most investors’ radar.</b></blockquote><p>Overheated markets make it increasingly difficult to identify attractively priced investments. But with hordes of buyers plunking capital onmeme stocks and cryptocurrencies,quality shareholders (aka buy-and-hold stock pickers) continue to see opportunities for the long term.</p><p>Take&nbsp;Boyar Value Group. Since 1975, it has provided insightful research on a range of businesses. The father and son team of Mark and Jonathan Boyar also eat their own cooking, being quality shareholders (QSs) themselves as operators of the Boyar Value FundBOYAX,+0.48%.</p><p>The Boyars have been prescient: shortly after the coronavirus pandemic hit and took down the U.S. stock market, they&nbsp;released a special report&nbsp;detailing 19 companies whose shares they recommended amid the selloff.&nbsp; One year later, a portfolio of those stocks was up 78%, besting the S&amp;P 500SPX,+0.19%by 27 percentage points.</p><p>Boyar Value Group produces the&nbsp;“Forgotten Forty,” a year-end report on 40 stocks they view as overlooked. &nbsp;Barron’s highlighted seven&nbsp;of the picks earlier this year — a diverse mix that included Bank of AmericaBAC,+0.07%,Liberty Braves GroupBATRA,+1.26%,and SyscoSYY,-0.52%.This year’s Forgotten Forty&nbsp;has gained 17% since late December versus 12% for the S&amp;P 500.</p><p>Boyar’s&nbsp;Forgotten Forty&nbsp;is an excellent filter for stock pickers as they narrow their hunt. One way to tailor picks is to cross-check these 40 companies with those of companies that score high for&nbsp;attracting QSs.</p><p>Many investors mimic the portfolio of uber-QS Warren Buffett of Berkshire HathawayBRK.A,+0.12%BRK.B,+0.05%,for instance. Other QSs can be identified using such resources as Martijn Cremmers’&nbsp;active share rankings, proprietary data analytics of&nbsp;EQX, or research of my&nbsp;ownQuality Shareholders Initiative&nbsp;(QSI) — all useful tools to construct a&nbsp;high-performing portfolio.</p><p>Combining the&nbsp;Forgotten Forty&nbsp;with such data, below are three stock ideas to consider as part of a larger portfolio. (Of course, this is not investing advice or a recommendation to buy — just a few suggestions to consider.)</p><p><b>UniFirst Corporation</b></p><p>UniFirst Corp.UNF,+2.13%,founded by the Croatti family in a Boston barn in 1936, is a uniform rental company currently employing more than 14,000 in 260 facilities in North America and Europe and generating nearly $2 billion in annual revenue. It is number three in an oligopolistic industry — along with AramarkARMK,+0.27%and CintasCTAS,-0.37%,the trio commands 70% of the market — which enables rational industry pricing.</p><p>UniFirst’s core laundry business runs on multiyear contracts, creating recurring revenue. Customer retention rates are high and employee tenures are long, and the company carries no debt.&nbsp; Along with a strong cash position, the U.S. economic reopening ahead bodes well, particularly with UniFirst’s large customer base in the energy sector. Boyar’s valuation: $263 per share, well-above recent levels.</p><p>Members of the Croatti family are major shareholders, with 20% of the economic interest and 71% of the voting power, under a dual-class capital structure.&nbsp;Despite how some governance gurus roundly condemn dual class structures, QSI data indicates that&nbsp;QSs examine the practice&nbsp;on a case-by-case basis.</p><p>UniFirst is a magnet for QSs, increasingly so in recent years as the company has enhanced its capital allocation rationality through share buybacks and dividends. In terms of concentration levels and holding periods, the company’s shareholders treat it far better than they treat their other investees, EQX data indicates.&nbsp; A sampling of UniFirst’s QSs: Aurora Investment Counsel, Copeland Capital Management, Hunter Perkins Capital Management, London Company of Virginia and River Road Asset Management.</p><p><b>Comcast Corporation</b></p><p>ComcastCMCSA,+2.06%,a cable industry pioneer founded by Ralph Roberts in 1963, is a global communications powerhouse with diverse investments in related sectors, especially in technology. The business, with annual revenues exceeding $100 billion, proved resilient during the pandemic, with durable strengths in both broadband and streaming, and an expected bounce from reopening of its theme parks.</p><p>Communications businesses such as Comcast’s combine highly valuable intangible assets with little need for reinvestment in tangible assets—particularly appealing during inflationary periods. Boyar’s valuation: $76 per share, comfortably above market.</p><p>Comcast is another magnet for QSs, and another dual class company, in which Brian Roberts holds 1% of the economic interest along with 34% of the voting power. Among QSs owning Comcast shares: Eagle Capital, First Pacific Advisors, Rothschild &amp; Co. and Southeastern Asset Management. Note also: Nelson Peltz’s Trian Fund accumulated a large stake, about 0.4%, in several transactions during 2020.</p><p><b>Bank of New York Mellon</b></p><p>Bank of New York MellonBK,+0.86%is the world’s largest custodian bank and asset servicing company, with $2 trillion in assets under management and close to $40 trillion in assets under custody. The company is a blend of two storied institutions: Bank of New York has roots back to Alexander Hamilton and Aaron Burr in 1784, while Mellon traces to the bank Andrew Mellon began in 1869.</p><p>Today, with annual revenues reaching $16 billion, the firm is distinguished for achieving outsized cost savings from a high-tech digitized platform. It is using artificial intelligence and machine learning to automate many functions, from financial calculations to client inquiries. BNY Mellon’s scale in the custodian business positions it well to win the trillion-dollar accounts of the world’s largest asset managers.</p><p>Boyar’s valuation for BNY Mellon is a conservative $50 per share, suggesting there’s still some upside. BNY Mellon enjoys one of the highest-quality shareholder bases in the US, according to EQX and QSI research. Prominent QSs include: Berkshire Hathaway, Davis Selected Advisers, Dodge &amp; Cox, Lountzis Asset Management and Tweedy Browne.</p><p>Three picks do not a portfolio make, of course. So consider these other interesting ideas from the Boyar&nbsp;Forgotten Forty&nbsp;that also boast high-quality shareholder followings: Walt DisneyDIS,+0.17%,IAC/InterActiveCorp.IAC,+3.19%and MerckMRK,-0.35%.</p><p>In a volatile market like now, all of these companies offer a substantial measure of stability.&nbsp; For veteran investors and newcomers alike, keep in mind that it is foolish to follow the herd, and wise to heed the thoughtful.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: These cool, high-quality stocks are just right for this overheated, overvalued market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: These cool, high-quality stocks are just right for this overheated, overvalued market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-27 11:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/these-cool-high-quality-stocks-are-just-right-for-this-overheated-overvalued-market-11621994657><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Well-managed companies boast strong cash flow, a stable shareholder base, and are under most investors’ radar.Overheated markets make it increasingly difficult to identify attractively priced ...</p>\n\n<a href=\"https://www.marketwatch.com/story/these-cool-high-quality-stocks-are-just-right-for-this-overheated-overvalued-market-11621994657\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/these-cool-high-quality-stocks-are-just-right-for-this-overheated-overvalued-market-11621994657","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193634953","content_text":"Well-managed companies boast strong cash flow, a stable shareholder base, and are under most investors’ radar.Overheated markets make it increasingly difficult to identify attractively priced investments. But with hordes of buyers plunking capital onmeme stocks and cryptocurrencies,quality shareholders (aka buy-and-hold stock pickers) continue to see opportunities for the long term.Take Boyar Value Group. Since 1975, it has provided insightful research on a range of businesses. The father and son team of Mark and Jonathan Boyar also eat their own cooking, being quality shareholders (QSs) themselves as operators of the Boyar Value FundBOYAX,+0.48%.The Boyars have been prescient: shortly after the coronavirus pandemic hit and took down the U.S. stock market, they released a special report detailing 19 companies whose shares they recommended amid the selloff.  One year later, a portfolio of those stocks was up 78%, besting the S&P 500SPX,+0.19%by 27 percentage points.Boyar Value Group produces the “Forgotten Forty,” a year-end report on 40 stocks they view as overlooked.  Barron’s highlighted seven of the picks earlier this year — a diverse mix that included Bank of AmericaBAC,+0.07%,Liberty Braves GroupBATRA,+1.26%,and SyscoSYY,-0.52%.This year’s Forgotten Forty has gained 17% since late December versus 12% for the S&P 500.Boyar’s Forgotten Forty is an excellent filter for stock pickers as they narrow their hunt. One way to tailor picks is to cross-check these 40 companies with those of companies that score high for attracting QSs.Many investors mimic the portfolio of uber-QS Warren Buffett of Berkshire HathawayBRK.A,+0.12%BRK.B,+0.05%,for instance. Other QSs can be identified using such resources as Martijn Cremmers’ active share rankings, proprietary data analytics of EQX, or research of my ownQuality Shareholders Initiative (QSI) — all useful tools to construct a high-performing portfolio.Combining the Forgotten Forty with such data, below are three stock ideas to consider as part of a larger portfolio. (Of course, this is not investing advice or a recommendation to buy — just a few suggestions to consider.)UniFirst CorporationUniFirst Corp.UNF,+2.13%,founded by the Croatti family in a Boston barn in 1936, is a uniform rental company currently employing more than 14,000 in 260 facilities in North America and Europe and generating nearly $2 billion in annual revenue. It is number three in an oligopolistic industry — along with AramarkARMK,+0.27%and CintasCTAS,-0.37%,the trio commands 70% of the market — which enables rational industry pricing.UniFirst’s core laundry business runs on multiyear contracts, creating recurring revenue. Customer retention rates are high and employee tenures are long, and the company carries no debt.  Along with a strong cash position, the U.S. economic reopening ahead bodes well, particularly with UniFirst’s large customer base in the energy sector. Boyar’s valuation: $263 per share, well-above recent levels.Members of the Croatti family are major shareholders, with 20% of the economic interest and 71% of the voting power, under a dual-class capital structure. Despite how some governance gurus roundly condemn dual class structures, QSI data indicates that QSs examine the practice on a case-by-case basis.UniFirst is a magnet for QSs, increasingly so in recent years as the company has enhanced its capital allocation rationality through share buybacks and dividends. In terms of concentration levels and holding periods, the company’s shareholders treat it far better than they treat their other investees, EQX data indicates.  A sampling of UniFirst’s QSs: Aurora Investment Counsel, Copeland Capital Management, Hunter Perkins Capital Management, London Company of Virginia and River Road Asset Management.Comcast CorporationComcastCMCSA,+2.06%,a cable industry pioneer founded by Ralph Roberts in 1963, is a global communications powerhouse with diverse investments in related sectors, especially in technology. The business, with annual revenues exceeding $100 billion, proved resilient during the pandemic, with durable strengths in both broadband and streaming, and an expected bounce from reopening of its theme parks.Communications businesses such as Comcast’s combine highly valuable intangible assets with little need for reinvestment in tangible assets—particularly appealing during inflationary periods. Boyar’s valuation: $76 per share, comfortably above market.Comcast is another magnet for QSs, and another dual class company, in which Brian Roberts holds 1% of the economic interest along with 34% of the voting power. Among QSs owning Comcast shares: Eagle Capital, First Pacific Advisors, Rothschild & Co. and Southeastern Asset Management. Note also: Nelson Peltz’s Trian Fund accumulated a large stake, about 0.4%, in several transactions during 2020.Bank of New York MellonBank of New York MellonBK,+0.86%is the world’s largest custodian bank and asset servicing company, with $2 trillion in assets under management and close to $40 trillion in assets under custody. The company is a blend of two storied institutions: Bank of New York has roots back to Alexander Hamilton and Aaron Burr in 1784, while Mellon traces to the bank Andrew Mellon began in 1869.Today, with annual revenues reaching $16 billion, the firm is distinguished for achieving outsized cost savings from a high-tech digitized platform. It is using artificial intelligence and machine learning to automate many functions, from financial calculations to client inquiries. BNY Mellon’s scale in the custodian business positions it well to win the trillion-dollar accounts of the world’s largest asset managers.Boyar’s valuation for BNY Mellon is a conservative $50 per share, suggesting there’s still some upside. BNY Mellon enjoys one of the highest-quality shareholder bases in the US, according to EQX and QSI research. Prominent QSs include: Berkshire Hathaway, Davis Selected Advisers, Dodge & Cox, Lountzis Asset Management and Tweedy Browne.Three picks do not a portfolio make, of course. So consider these other interesting ideas from the Boyar Forgotten Forty that also boast high-quality shareholder followings: Walt DisneyDIS,+0.17%,IAC/InterActiveCorp.IAC,+3.19%and MerckMRK,-0.35%.In a volatile market like now, all of these companies offer a substantial measure of stability.  For veteran investors and newcomers alike, keep in mind that it is foolish to follow the herd, and wise to heed the thoughtful.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":1394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138288117,"gmtCreate":1621943153039,"gmtModify":1634185306958,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Lnc","listText":"Lnc","text":"Lnc","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/138288117","repostId":"2138164416","repostType":4,"isVote":1,"tweetType":1,"viewCount":2241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":131160238,"gmtCreate":1621836383424,"gmtModify":1634186199715,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/131160238","repostId":"1185350425","repostType":4,"repost":{"id":"1185350425","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1621835821,"share":"https://www.laohu8.com/m/news/1185350425?lang=&edition=full","pubTime":"2021-05-24 13:57","market":"us","language":"en","title":"Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=1185350425","media":"Benzinga","summary":"Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherape","content":"<p>Cathie Wood-led Ark Investment Management is betting that despite recent setbacks&nbsp;<b>Iovance Biotherapeutics Inc</b>&nbsp;IOVA 3.73%&nbsp;will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.</p><p><b>What Happened:</b>&nbsp;IOVA shares have declined 32% since Tuesday after the California-based&nbsp;biotech startup&nbsp;delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.</p><p>The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.</p><p>Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO.&nbsp;Shares fell 39% on Wednesday after the announcement.</p><p>The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.</p><p>The&nbsp;<b>Ark Genomic Revolution</b>&nbsp;ETF (BATS:ARKG) and the<b>Ark Innovation ETF</b>&nbsp;ARKK 0.75%&nbsp;carry the stake in IOVA.</p><p>“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.</p><p>“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”</p><p><b>Price Action:</b>&nbsp;IOVA shares closed 3.73% lower at $18.05 on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-05-24 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cathie Wood-led Ark Investment Management is betting that despite recent setbacks&nbsp;<b>Iovance Biotherapeutics Inc</b>&nbsp;IOVA 3.73%&nbsp;will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.</p><p><b>What Happened:</b>&nbsp;IOVA shares have declined 32% since Tuesday after the California-based&nbsp;biotech startup&nbsp;delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.</p><p>The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.</p><p>Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO.&nbsp;Shares fell 39% on Wednesday after the announcement.</p><p>The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.</p><p>The&nbsp;<b>Ark Genomic Revolution</b>&nbsp;ETF (BATS:ARKG) and the<b>Ark Innovation ETF</b>&nbsp;ARKK 0.75%&nbsp;carry the stake in IOVA.</p><p>“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.</p><p>“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”</p><p><b>Price Action:</b>&nbsp;IOVA shares closed 3.73% lower at $18.05 on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKG":"ARK Genomic Revolution ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185350425","content_text":"Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherapeutics Inc IOVA 3.73% will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.What Happened: IOVA shares have declined 32% since Tuesday after the California-based biotech startup delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO. Shares fell 39% on Wednesday after the announcement.The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.The Ark Genomic Revolution ETF (BATS:ARKG) and theArk Innovation ETF ARKK 0.75% carry the stake in IOVA.“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”Price Action: IOVA shares closed 3.73% lower at $18.05 on Friday.","news_type":1,"symbols_score_info":{"ARKG":0.9,"ARKK":0.9,"IOVA":0.9}},"isVote":1,"tweetType":1,"viewCount":585,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133235322,"gmtCreate":1621751299966,"gmtModify":1634186772566,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/133235322","repostId":"2137906121","repostType":4,"isVote":1,"tweetType":1,"viewCount":639,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133065265,"gmtCreate":1621670841257,"gmtModify":1634187223594,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/133065265","repostId":"1198772655","repostType":4,"isVote":1,"tweetType":1,"viewCount":377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":199900130,"gmtCreate":1620659563220,"gmtModify":1634197321105,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Comment thanksss","listText":"Comment thanksss","text":"Comment thanksss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/199900130","repostId":"1152509517","repostType":4,"isVote":1,"tweetType":1,"viewCount":668,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101191173,"gmtCreate":1619855482792,"gmtModify":1634209445395,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581817202947175","authorIdStr":"3581817202947175"},"themes":[],"htmlText":"Wa","listText":"Wa","text":"Wa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/101191173","repostId":"1138497242","repostType":4,"isVote":1,"tweetType":1,"viewCount":717,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":133065265,"gmtCreate":1621670841257,"gmtModify":1634187223594,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/133065265","repostId":"1198772655","repostType":4,"isVote":1,"tweetType":1,"viewCount":377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137970181,"gmtCreate":1622292004043,"gmtModify":1634102486086,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/137970181","repostId":"2138948877","repostType":4,"isVote":1,"tweetType":1,"viewCount":1281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138288117,"gmtCreate":1621943153039,"gmtModify":1634185306958,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Lnc","listText":"Lnc","text":"Lnc","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/138288117","repostId":"2138164416","repostType":4,"isVote":1,"tweetType":1,"viewCount":2241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119112024,"gmtCreate":1622526473668,"gmtModify":1634100797230,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/119112024","repostId":"1105273964","repostType":4,"repost":{"id":"1105273964","kind":"news","pubTimestamp":1622511256,"share":"https://www.laohu8.com/m/news/1105273964?lang=&edition=full","pubTime":"2021-06-01 09:34","market":"hk","language":"en","title":"Here Are the 11 Best Performing IPOs of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1105273964","media":"Barron's","summary":"The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.That left us with 11 names. First up:CureVac, which was the screen’s best-performing IPO and had a total return of 596.75%. CureVac specializes in the messenger RNA, or mRNA, technology that is the basis of several leading Covid-19 vaccine programs. The German biotech company went public inAugust at $16 a shareand soared 249% in its ","content":"<p>The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.</p><p>But not everyone receives these types of opportunities. Most retail investors have to wait until companies start publicly trading to buy stock.<i>Barron’s</i>looked at businesses that have gone public in the past 12 months to find some strong performers.</p><p>First, we searched for companies that listed via a traditional initial public offering: This meant we filtered out businesses that merged withspecial purpose acquisition companies, or SPACs. Then, we searched for companies that went public on either the New York Stock Exchange or the Nasdaq. We also focused on entities that had at least a $1 billion market capitalization. We narrowed our search to companies with the highesttotal returns from their stock offering prices..</p><p>That left us with 11 names. First up:CureVac(ticker: CVAC), which was the screen’s best-performing IPO and had a total return of 596.75%. CureVac specializes in the messenger RNA, or mRNA, technology that is the basis of several leading Covid-19 vaccine programs. The German biotech company went public inAugust at $16 a shareand soared 249% in its first day, with the stock closing at $55.90. In January, CureVacstruck a deal with Bayerto accelerate the development and supply of its Covid-19 vaccine candidate. The company’s mRNA-based Covid-19 vaccine is now in clinical trials, and Phase2b/3 data is expected this summer. Since its IPO, the stock has nearly doubled, closingFriday at $111.48 .</p><p>Strong performances need not be dictated by success on the first day of trading. Four of the companies that made our list were busted deals—meaning that their shares fell below their IPO prices on the first day of trading.</p><p>Case in point:ZIM Integrated Shipping(ZIM). The asset-light shipping company went public in January with a $15 offering price,but closed that day at $11.50. Yet by May 19, ZIM’s stockhad gained 295%after itreported first-quarter earnings of $589.6 million, or $5.35 a share. The companyalso declared a special cash dividend of $2 a share. ZIM is the second-best-performing IPO in the past 12 months, based on a total return of 209.33%, according to FactSet. It closed on Friday at $46.40.</p><p>Another example isAcademy Sports &amp; Outdoors(ASO): The companywent public in Octoberwith a $13 offering price, with the stock closing at $12.99 during its first day of public trading<b>.</b>Academy was profitable when it went public, a rarity in the IPO market. InMarch, the company reported that its net incomesoared 416%, to $91.5 million, or 97 cents a share, for its fourth fiscal quarter ended Jan. 30. Its shares have nearly tripled since the IPO, and were trading at $36.53 on Friday. Academy Sports ranks third with a total return from the offering price of 181%, FactSet said.</p><p>Strong GainersThese companies all went public in the last year and produced high total returns compared to their IPO prices.<img src=\"https://static.tigerbbs.com/9dedc209ede147958c015d3a586bb587\" tg-width=\"630\" tg-height=\"606\">Rounding out this category areCorsair Gaming(CRSR), a California companythat makes performance gear for gamers, and the Dubai-basedYalla Group(YALA), whichmakes a voice-chat app usedin the Middle East and North Africa called Yalla. Both stocks have rebounded strongly after less-than-stellar September IPOs.</p><p>Some companies that made our list soared during their debuts, but have since seen their shares retreat. Still, these companies are producing gains.</p><p>ConsiderBigCommerce(BIGC), which provides a cloud e-commerce platform that is used by such customers as SkullCandy, Savannah Bee Co, and the Cleveland Cavaliers.BigCommerce&nbsp;went public in Augustwith a $24 offering price—and the stock soared 201% that day,closing at $72.27. Since the IPO, the shares have fallen nearly 25%, amid a broader technology selloff.</p><p>The company, however, has reported some positive developments, like a deal in February that wouldgive BigCommerce customersthe ability to sell directly on Walmart Marketplace. It also reported better-than-expected fourth-quarter results. BigCommerce has produced a total return of nearly 127%, according to FactSet.</p><p>Other companies have seen their shares jump since going public.Dream Finders Homes (DFH), which designs, builds, and sells homes in high-growth markets, was already profitable when it made its trading debut in January at $13 a share. Shares soared 61%, $20.95 on its first day.Prices for houses in Marchgrew at the fastest rate since 2005, which has helped real estate stocks. Dream Finders stock has gained nearly 52% since its IPO, trading Friday at $31.77. Dream Finders notched a total return from offering price of 144.38%.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here Are the 11 Best Performing IPOs of the Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere Are the 11 Best Performing IPOs of the Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-01 09:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/here-are-the-11-best-performing-ipos-of-the-year-51622472529?mod=hp_DAY_0><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.But not everyone receives these ...</p>\n\n<a href=\"https://www.barrons.com/articles/here-are-the-11-best-performing-ipos-of-the-year-51622472529?mod=hp_DAY_0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/here-are-the-11-best-performing-ipos-of-the-year-51622472529?mod=hp_DAY_0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105273964","content_text":"The market for initial public offerings has recently delivered some great first-day gains for investors who were able to get shares before the companies went public.But not everyone receives these types of opportunities. Most retail investors have to wait until companies start publicly trading to buy stock.Barron’slooked at businesses that have gone public in the past 12 months to find some strong performers.First, we searched for companies that listed via a traditional initial public offering: This meant we filtered out businesses that merged withspecial purpose acquisition companies, or SPACs. Then, we searched for companies that went public on either the New York Stock Exchange or the Nasdaq. We also focused on entities that had at least a $1 billion market capitalization. We narrowed our search to companies with the highesttotal returns from their stock offering prices..That left us with 11 names. First up:CureVac(ticker: CVAC), which was the screen’s best-performing IPO and had a total return of 596.75%. CureVac specializes in the messenger RNA, or mRNA, technology that is the basis of several leading Covid-19 vaccine programs. The German biotech company went public inAugust at $16 a shareand soared 249% in its first day, with the stock closing at $55.90. In January, CureVacstruck a deal with Bayerto accelerate the development and supply of its Covid-19 vaccine candidate. The company’s mRNA-based Covid-19 vaccine is now in clinical trials, and Phase2b/3 data is expected this summer. Since its IPO, the stock has nearly doubled, closingFriday at $111.48 .Strong performances need not be dictated by success on the first day of trading. Four of the companies that made our list were busted deals—meaning that their shares fell below their IPO prices on the first day of trading.Case in point:ZIM Integrated Shipping(ZIM). The asset-light shipping company went public in January with a $15 offering price,but closed that day at $11.50. Yet by May 19, ZIM’s stockhad gained 295%after itreported first-quarter earnings of $589.6 million, or $5.35 a share. The companyalso declared a special cash dividend of $2 a share. ZIM is the second-best-performing IPO in the past 12 months, based on a total return of 209.33%, according to FactSet. It closed on Friday at $46.40.Another example isAcademy Sports & Outdoors(ASO): The companywent public in Octoberwith a $13 offering price, with the stock closing at $12.99 during its first day of public trading.Academy was profitable when it went public, a rarity in the IPO market. InMarch, the company reported that its net incomesoared 416%, to $91.5 million, or 97 cents a share, for its fourth fiscal quarter ended Jan. 30. Its shares have nearly tripled since the IPO, and were trading at $36.53 on Friday. Academy Sports ranks third with a total return from the offering price of 181%, FactSet said.Strong GainersThese companies all went public in the last year and produced high total returns compared to their IPO prices.Rounding out this category areCorsair Gaming(CRSR), a California companythat makes performance gear for gamers, and the Dubai-basedYalla Group(YALA), whichmakes a voice-chat app usedin the Middle East and North Africa called Yalla. Both stocks have rebounded strongly after less-than-stellar September IPOs.Some companies that made our list soared during their debuts, but have since seen their shares retreat. Still, these companies are producing gains.ConsiderBigCommerce(BIGC), which provides a cloud e-commerce platform that is used by such customers as SkullCandy, Savannah Bee Co, and the Cleveland Cavaliers.BigCommerce went public in Augustwith a $24 offering price—and the stock soared 201% that day,closing at $72.27. Since the IPO, the shares have fallen nearly 25%, amid a broader technology selloff.The company, however, has reported some positive developments, like a deal in February that wouldgive BigCommerce customersthe ability to sell directly on Walmart Marketplace. It also reported better-than-expected fourth-quarter results. BigCommerce has produced a total return of nearly 127%, according to FactSet.Other companies have seen their shares jump since going public.Dream Finders Homes (DFH), which designs, builds, and sells homes in high-growth markets, was already profitable when it made its trading debut in January at $13 a share. Shares soared 61%, $20.95 on its first day.Prices for houses in Marchgrew at the fastest rate since 2005, which has helped real estate stocks. Dream Finders stock has gained nearly 52% since its IPO, trading Friday at $31.77. Dream Finders notched a total return from offering price of 144.38%.","news_type":1,"symbols_score_info":{"BOTB.UK":0.9}},"isVote":1,"tweetType":1,"viewCount":1300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114141886,"gmtCreate":1623060373445,"gmtModify":1634037393370,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114141886","repostId":"1194257742","repostType":4,"repost":{"id":"1194257742","kind":"news","pubTimestamp":1623059574,"share":"https://www.laohu8.com/m/news/1194257742?lang=&edition=full","pubTime":"2021-06-07 17:52","market":"us","language":"en","title":"\"We Took Out The June 2007 Highs\": Morgan Stanley's Sell Signal Just Hit An All Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=1194257742","media":"zerohedge","summary":"For the past several months, Morgan Stanley's fundamental analysts have been turning increasingly be","content":"<p>For the past several months, Morgan Stanley's fundamental analysts have been turning increasingly bearish on stocks, with the pessimistic sentimentplateauing earlier this weekwhen chief equity strategist Michael Wilson said that there is far too much optimism in the market, and that while earnings are slowly rising, forward PE multiples are far too high and are set to slide, with \"the de-rating about 75% to go or an approximate 15% decline in P/Es from here.\" As a result, in Wilson's view - which is rapidly emerging as the most bearish on Wall Street - \"<b>earnings revisions will not be able to offset that de-rating, leaving the overall market vulnerable to a 10-15 % correction over the next 6 months.\"</b></p>\n<p><img src=\"https://static.tigerbbs.com/f72ac2b1254473a56a44d443d5b0af2e\" tg-width=\"500\" tg-height=\"298\" referrerpolicy=\"no-referrer\">It now appears that Morgan Stanley's fundamental bearishness has spilled over into the bank's technical analyst team and as the bank's chief Euro equity Strategist Matthew Garman writes,<b>for only the fifth time in over 30 years, each of Morgan Stanley's five market timing indicators are giving a sell signal at the same time.</b></p>\n<p>Not only that, but the bank's Combined Market Timing Indicator - which has been in sell territory since March - just hit a new all time high of 1.19, surpassing the previous record high seen in June-2007, right around the time of the first great quant crash and before the market collapsed.</p>\n<p>According to Garman, the only time equities have risen after a \"Full House\" Sell Signal was in Feb 17, shortly after the Shanghai Accord kicked in to prevent a global recession. The other previous occasions where there was a \"Full House\" Sell Signal were Mar-90, May-92, Jun-07. According to MS,<b>\"in the 6M post the initial Full House Sell Signal, MSCI Europe has fallen on average 6%</b>.\"</p>\n<p><img src=\"https://static.tigerbbs.com/840d972b24ae257679bd7334982d19d8\" tg-width=\"1130\" tg-height=\"415\" referrerpolicy=\"no-referrer\">So with every in house risk indicator screaming sell, does that mean that Morgan Stanley will have the balls to tell its clients to sell? Why of course not, because in this market where stuff like the AMC, GameStop and Bed Bath squeezes force analysts to admit they no longer have any idea what's going on...</p>\n<p><img src=\"https://static.tigerbbs.com/79e9d638925af010cddcb25105f8a4b0\" tg-width=\"500\" tg-height=\"471\" referrerpolicy=\"no-referrer\">... Morgan Stanley is keeping the hope and assuming that the current period will be similar to 2017 - the only other time when a massive sell signal did not result in a market plunge.</p>\n<blockquote>\n <i>Back in 2017, we remained constructive despite the signal given i) strong EPS growth, ii) an early cycle environment, iii) EU inflows, iv) low sentiment and v) a rise in M&amp;A. Sentiment metrics may look more elevated than in 2017, but many of those factors remain in place today. While we see a trickier risk-reward for equities globally, we maintain our view that there is a compelling case for Europe to outperform global peers.</i>\n</blockquote>\n<p>Yet even Morgan Stanley is forced to admit that while Defensives may just scrape by after a record sell signal, cyclicals are about to be hammered. The next chart shows the relative performance of Cyclicals versus Defensives after a Full House Sell Signal on. As MS notes, \"perhaps unsurprisingly, given the poor performance at the market level, Cyclicals have struggled. In the 6M post the four initial Full House Sell Signals, Cyclicals have underperformed Defensives on average 12%, and this drops to -15% looking at any day</p>\n<p>when the MTIs have all said sell at the same time.\"</p>\n<p>This was true even in 2017 when equity markets rose: \"we previously cited similarities with the 2017 Full House Sell Signal as reasons to not get overly cautious on equity markets in aggregate at this moment in time. After the February-2017 Full House Sell Signal, MSCI Europe continued to rise pretty consistently through the rest of the year. However, despite strong performance from the market in aggregate, the performance of Cyclicals versus Defensives was much poorer. Between February and June 2017 Cyclicals underperformed Defensives by 6%.\"</p>\n<p><img src=\"https://static.tigerbbs.com/8dcf00cdefd33fef071981aa4a5547a7\" tg-width=\"1084\" tg-height=\"387\" referrerpolicy=\"no-referrer\">It's not just the bank's sell signal that is prompting concerns about the future returns of cyclicals: Borrowing a page from our own warnings (see \"China's Credit Impulse Just Turned Negative, Unleashing Global Deflationary Shockwave\"), Morgan Stanley looks at \"a number of China data points which are giving warning signs\" first and foremost the collapse in China's credit impulse, to wit:</p>\n<p>While credit tightening has been front-loaded in 1H21, as outlined here, our economists remain constructive on China's growth recovery. Having said that, a number of Chinese data points do suggest the Cyclical bounce looks overextended.<b>China's credit impulse has just turned negative, and historically this has provided a lead indicator for the year-on-year performance of European Cyclicals (Exhibit 5).</b>Similarly, the relative performance of Cyclicals versus Defensives has closely tracked moves in Chinese 10Y bond yields, which are now at their lowest levels since September 2020, standing in sharp contrast to the performance of Cyclicals.</p>\n<p><img src=\"https://static.tigerbbs.com/c85032415626480364933f91dda387bf\" tg-width=\"1065\" tg-height=\"409\"></p>\n<p>Putting it all together, readers have to ask themselves if what is coming will be an analog of the one and only episode on history when the market did not plunge after all Morgan Stanley market timing indicators hit a sell (and were at an all time high), or will this case be similar to Mar-90, May-92, Jun-07 when the outcome was anything but a happy ending.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>\"We Took Out The June 2007 Highs\": Morgan Stanley's Sell Signal Just Hit An All Time High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n\"We Took Out The June 2007 Highs\": Morgan Stanley's Sell Signal Just Hit An All Time High\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 17:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/we-took-out-june-2007-highs-morgan-stanleys-sell-signal-just-hit-all-time-high><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For the past several months, Morgan Stanley's fundamental analysts have been turning increasingly bearish on stocks, with the pessimistic sentimentplateauing earlier this weekwhen chief equity ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/we-took-out-june-2007-highs-morgan-stanleys-sell-signal-just-hit-all-time-high\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index","SPY":"标普500ETF"},"source_url":"https://www.zerohedge.com/markets/we-took-out-june-2007-highs-morgan-stanleys-sell-signal-just-hit-all-time-high","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194257742","content_text":"For the past several months, Morgan Stanley's fundamental analysts have been turning increasingly bearish on stocks, with the pessimistic sentimentplateauing earlier this weekwhen chief equity strategist Michael Wilson said that there is far too much optimism in the market, and that while earnings are slowly rising, forward PE multiples are far too high and are set to slide, with \"the de-rating about 75% to go or an approximate 15% decline in P/Es from here.\" As a result, in Wilson's view - which is rapidly emerging as the most bearish on Wall Street - \"earnings revisions will not be able to offset that de-rating, leaving the overall market vulnerable to a 10-15 % correction over the next 6 months.\"\nIt now appears that Morgan Stanley's fundamental bearishness has spilled over into the bank's technical analyst team and as the bank's chief Euro equity Strategist Matthew Garman writes,for only the fifth time in over 30 years, each of Morgan Stanley's five market timing indicators are giving a sell signal at the same time.\nNot only that, but the bank's Combined Market Timing Indicator - which has been in sell territory since March - just hit a new all time high of 1.19, surpassing the previous record high seen in June-2007, right around the time of the first great quant crash and before the market collapsed.\nAccording to Garman, the only time equities have risen after a \"Full House\" Sell Signal was in Feb 17, shortly after the Shanghai Accord kicked in to prevent a global recession. The other previous occasions where there was a \"Full House\" Sell Signal were Mar-90, May-92, Jun-07. According to MS,\"in the 6M post the initial Full House Sell Signal, MSCI Europe has fallen on average 6%.\"\nSo with every in house risk indicator screaming sell, does that mean that Morgan Stanley will have the balls to tell its clients to sell? Why of course not, because in this market where stuff like the AMC, GameStop and Bed Bath squeezes force analysts to admit they no longer have any idea what's going on...\n... Morgan Stanley is keeping the hope and assuming that the current period will be similar to 2017 - the only other time when a massive sell signal did not result in a market plunge.\n\nBack in 2017, we remained constructive despite the signal given i) strong EPS growth, ii) an early cycle environment, iii) EU inflows, iv) low sentiment and v) a rise in M&A. Sentiment metrics may look more elevated than in 2017, but many of those factors remain in place today. While we see a trickier risk-reward for equities globally, we maintain our view that there is a compelling case for Europe to outperform global peers.\n\nYet even Morgan Stanley is forced to admit that while Defensives may just scrape by after a record sell signal, cyclicals are about to be hammered. The next chart shows the relative performance of Cyclicals versus Defensives after a Full House Sell Signal on. As MS notes, \"perhaps unsurprisingly, given the poor performance at the market level, Cyclicals have struggled. In the 6M post the four initial Full House Sell Signals, Cyclicals have underperformed Defensives on average 12%, and this drops to -15% looking at any day\nwhen the MTIs have all said sell at the same time.\"\nThis was true even in 2017 when equity markets rose: \"we previously cited similarities with the 2017 Full House Sell Signal as reasons to not get overly cautious on equity markets in aggregate at this moment in time. After the February-2017 Full House Sell Signal, MSCI Europe continued to rise pretty consistently through the rest of the year. However, despite strong performance from the market in aggregate, the performance of Cyclicals versus Defensives was much poorer. Between February and June 2017 Cyclicals underperformed Defensives by 6%.\"\nIt's not just the bank's sell signal that is prompting concerns about the future returns of cyclicals: Borrowing a page from our own warnings (see \"China's Credit Impulse Just Turned Negative, Unleashing Global Deflationary Shockwave\"), Morgan Stanley looks at \"a number of China data points which are giving warning signs\" first and foremost the collapse in China's credit impulse, to wit:\nWhile credit tightening has been front-loaded in 1H21, as outlined here, our economists remain constructive on China's growth recovery. Having said that, a number of Chinese data points do suggest the Cyclical bounce looks overextended.China's credit impulse has just turned negative, and historically this has provided a lead indicator for the year-on-year performance of European Cyclicals (Exhibit 5).Similarly, the relative performance of Cyclicals versus Defensives has closely tracked moves in Chinese 10Y bond yields, which are now at their lowest levels since September 2020, standing in sharp contrast to the performance of Cyclicals.\n\nPutting it all together, readers have to ask themselves if what is coming will be an analog of the one and only episode on history when the market did not plunge after all Morgan Stanley market timing indicators hit a sell (and were at an all time high), or will this case be similar to Mar-90, May-92, Jun-07 when the outcome was anything but a happy ending.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":1602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113805570,"gmtCreate":1622600962990,"gmtModify":1634100038118,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/113805570","repostId":"1188302386","repostType":4,"repost":{"id":"1188302386","kind":"news","pubTimestamp":1622598317,"share":"https://www.laohu8.com/m/news/1188302386?lang=&edition=full","pubTime":"2021-06-02 09:45","market":"hk","language":"en","title":"Robinhood Adds 3 Directors, Boosting Board Ahead of IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1188302386","media":"Barron's","summary":"Robinhood, on the cusp of going public, is now adding board members who can make the case that the u","content":"<p>Robinhood, on the cusp of going public, is now adding board members who can make the case that the upstart broker is ready to take a central place in the investment universe.</p>\n<p>The zero-commission investment app announced on Tuesday that it was adding three independent board members. Jon Rubinstein, a senior advisor at asset management firm PDT Partners who is a former <a href=\"https://laohu8.com/S/AAPL\">Apple</a> executive and the lead independent director at<a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a>(ticker: AMZN), adds mainstream tech experience. Paula Loop, a partner at PwC, has experience in governance, accounting, and Securities and Exchange Commission compliance. And Robert Zoellick, a fellow at Harvard University, is a former president of the World Bank and U.S. Trade Representative. That brings Robinhood’s board to seven members, two of whom are co-founders Vlad Tenev and Baiju Bhatt. The company declined to make any directors available for interviews.</p>\n<p>After disrupting the traditional brokerage industry, Robinhood is expected to go public as soon as this month. Itconfidentially filed paperswith the SEC in March. Some analysts think the company could fetch a valuation of $40 billion. Adding directors with strong reputations will likely help Robinhood’s case, although those directors are now tying their reputations to a company that has attracted considerable negative attention as well.</p>\n<p>Robinhood has walked a fine line over the past year, portraying itself to customers as a threat to the establishment. The founders have said they were inspired by the Occupy Wall Street movement to fight the power of big banks and brokers. At the same time, the company has sold itself to regulators as a responsible operator ready to take an even bigger role in the country’s financial infrastructure.</p>\n<p>Since the start of the pandemic, Robinhood has had to answer for a variety of irregularities, includingtrading outages last March, anda ban on purchases of certain stocksat the height of the<a href=\"https://laohu8.com/S/GME\">GameStop</a>(GME) frenzy in January. Massachusetts’ top securities regulator hassued the companyon allegations that it encourages risky trading for its own profit, a charge the company denies. Robinhood’s challenge will be to maintain its rebellious reputation, while also convincing regulators and customers that it is a responsible steward of their money.</p>\n<p>The next few weeks will determine how well it can make its pitch on Wall Street.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Robinhood Adds 3 Directors, Boosting Board Ahead of IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRobinhood Adds 3 Directors, Boosting Board Ahead of IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 09:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/robinhood-adds-3-directors-boosting-board-ahead-of-ipo-51622574302?mod=hp_LEAD_2><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Robinhood, on the cusp of going public, is now adding board members who can make the case that the upstart broker is ready to take a central place in the investment universe.\nThe zero-commission ...</p>\n\n<a href=\"https://www.barrons.com/articles/robinhood-adds-3-directors-boosting-board-ahead-of-ipo-51622574302?mod=hp_LEAD_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/robinhood-adds-3-directors-boosting-board-ahead-of-ipo-51622574302?mod=hp_LEAD_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188302386","content_text":"Robinhood, on the cusp of going public, is now adding board members who can make the case that the upstart broker is ready to take a central place in the investment universe.\nThe zero-commission investment app announced on Tuesday that it was adding three independent board members. Jon Rubinstein, a senior advisor at asset management firm PDT Partners who is a former Apple executive and the lead independent director atAmazon.com(ticker: AMZN), adds mainstream tech experience. Paula Loop, a partner at PwC, has experience in governance, accounting, and Securities and Exchange Commission compliance. And Robert Zoellick, a fellow at Harvard University, is a former president of the World Bank and U.S. Trade Representative. That brings Robinhood’s board to seven members, two of whom are co-founders Vlad Tenev and Baiju Bhatt. The company declined to make any directors available for interviews.\nAfter disrupting the traditional brokerage industry, Robinhood is expected to go public as soon as this month. Itconfidentially filed paperswith the SEC in March. Some analysts think the company could fetch a valuation of $40 billion. Adding directors with strong reputations will likely help Robinhood’s case, although those directors are now tying their reputations to a company that has attracted considerable negative attention as well.\nRobinhood has walked a fine line over the past year, portraying itself to customers as a threat to the establishment. The founders have said they were inspired by the Occupy Wall Street movement to fight the power of big banks and brokers. At the same time, the company has sold itself to regulators as a responsible operator ready to take an even bigger role in the country’s financial infrastructure.\nSince the start of the pandemic, Robinhood has had to answer for a variety of irregularities, includingtrading outages last March, anda ban on purchases of certain stocksat the height of theGameStop(GME) frenzy in January. Massachusetts’ top securities regulator hassued the companyon allegations that it encourages risky trading for its own profit, a charge the company denies. Robinhood’s challenge will be to maintain its rebellious reputation, while also convincing regulators and customers that it is a responsible steward of their money.\nThe next few weeks will determine how well it can make its pitch on Wall Street.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133235322,"gmtCreate":1621751299966,"gmtModify":1634186772566,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/133235322","repostId":"2137906121","repostType":4,"isVote":1,"tweetType":1,"viewCount":639,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":131160238,"gmtCreate":1621836383424,"gmtModify":1634186199715,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/131160238","repostId":"1185350425","repostType":4,"repost":{"id":"1185350425","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1621835821,"share":"https://www.laohu8.com/m/news/1185350425?lang=&edition=full","pubTime":"2021-05-24 13:57","market":"us","language":"en","title":"Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=1185350425","media":"Benzinga","summary":"Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherape","content":"<p>Cathie Wood-led Ark Investment Management is betting that despite recent setbacks&nbsp;<b>Iovance Biotherapeutics Inc</b>&nbsp;IOVA 3.73%&nbsp;will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.</p><p><b>What Happened:</b>&nbsp;IOVA shares have declined 32% since Tuesday after the California-based&nbsp;biotech startup&nbsp;delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.</p><p>The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.</p><p>Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO.&nbsp;Shares fell 39% on Wednesday after the announcement.</p><p>The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.</p><p>The&nbsp;<b>Ark Genomic Revolution</b>&nbsp;ETF (BATS:ARKG) and the<b>Ark Innovation ETF</b>&nbsp;ARKK 0.75%&nbsp;carry the stake in IOVA.</p><p>“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.</p><p>“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”</p><p><b>Price Action:</b>&nbsp;IOVA shares closed 3.73% lower at $18.05 on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-05-24 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cathie Wood-led Ark Investment Management is betting that despite recent setbacks&nbsp;<b>Iovance Biotherapeutics Inc</b>&nbsp;IOVA 3.73%&nbsp;will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.</p><p><b>What Happened:</b>&nbsp;IOVA shares have declined 32% since Tuesday after the California-based&nbsp;biotech startup&nbsp;delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.</p><p>The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.</p><p>Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO.&nbsp;Shares fell 39% on Wednesday after the announcement.</p><p>The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.</p><p>The&nbsp;<b>Ark Genomic Revolution</b>&nbsp;ETF (BATS:ARKG) and the<b>Ark Innovation ETF</b>&nbsp;ARKK 0.75%&nbsp;carry the stake in IOVA.</p><p>“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.</p><p>“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”</p><p><b>Price Action:</b>&nbsp;IOVA shares closed 3.73% lower at $18.05 on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKG":"ARK Genomic Revolution ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185350425","content_text":"Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherapeutics Inc IOVA 3.73% will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.What Happened: IOVA shares have declined 32% since Tuesday after the California-based biotech startup delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO. Shares fell 39% on Wednesday after the announcement.The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.The Ark Genomic Revolution ETF (BATS:ARKG) and theArk Innovation ETF ARKK 0.75% carry the stake in IOVA.“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”Price Action: IOVA shares closed 3.73% lower at $18.05 on Friday.","news_type":1,"symbols_score_info":{"ARKG":0.9,"ARKK":0.9,"IOVA":0.9}},"isVote":1,"tweetType":1,"viewCount":585,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":199900130,"gmtCreate":1620659563220,"gmtModify":1634197321105,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Comment thanksss","listText":"Comment thanksss","text":"Comment thanksss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/199900130","repostId":"1152509517","repostType":4,"isVote":1,"tweetType":1,"viewCount":668,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101191173,"gmtCreate":1619855482792,"gmtModify":1634209445395,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Wa","listText":"Wa","text":"Wa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/101191173","repostId":"1138497242","repostType":4,"isVote":1,"tweetType":1,"viewCount":717,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116958887,"gmtCreate":1622771076449,"gmtModify":1634098181507,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/116958887","repostId":"1110094207","repostType":4,"isVote":1,"tweetType":1,"viewCount":1118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":110805166,"gmtCreate":1622435620155,"gmtModify":1634101483775,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/110805166","repostId":"2139487733","repostType":4,"isVote":1,"tweetType":1,"viewCount":1326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":132283629,"gmtCreate":1622091529161,"gmtModify":1634183908138,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/132283629","repostId":"1193634953","repostType":4,"repost":{"id":"1193634953","kind":"news","pubTimestamp":1622087134,"share":"https://www.laohu8.com/m/news/1193634953?lang=&edition=full","pubTime":"2021-05-27 11:45","market":"us","language":"en","title":"Opinion: These cool, high-quality stocks are just right for this overheated, overvalued market","url":"https://stock-news.laohu8.com/highlight/detail?id=1193634953","media":"MarketWatch","summary":"Well-managed companies boast strong cash flow, a stable shareholder base, and are under most investo","content":"<blockquote><b>Well-managed companies boast strong cash flow, a stable shareholder base, and are under most investors’ radar.</b></blockquote><p>Overheated markets make it increasingly difficult to identify attractively priced investments. But with hordes of buyers plunking capital onmeme stocks and cryptocurrencies,quality shareholders (aka buy-and-hold stock pickers) continue to see opportunities for the long term.</p><p>Take&nbsp;Boyar Value Group. Since 1975, it has provided insightful research on a range of businesses. The father and son team of Mark and Jonathan Boyar also eat their own cooking, being quality shareholders (QSs) themselves as operators of the Boyar Value FundBOYAX,+0.48%.</p><p>The Boyars have been prescient: shortly after the coronavirus pandemic hit and took down the U.S. stock market, they&nbsp;released a special report&nbsp;detailing 19 companies whose shares they recommended amid the selloff.&nbsp; One year later, a portfolio of those stocks was up 78%, besting the S&amp;P 500SPX,+0.19%by 27 percentage points.</p><p>Boyar Value Group produces the&nbsp;“Forgotten Forty,” a year-end report on 40 stocks they view as overlooked. &nbsp;Barron’s highlighted seven&nbsp;of the picks earlier this year — a diverse mix that included Bank of AmericaBAC,+0.07%,Liberty Braves GroupBATRA,+1.26%,and SyscoSYY,-0.52%.This year’s Forgotten Forty&nbsp;has gained 17% since late December versus 12% for the S&amp;P 500.</p><p>Boyar’s&nbsp;Forgotten Forty&nbsp;is an excellent filter for stock pickers as they narrow their hunt. One way to tailor picks is to cross-check these 40 companies with those of companies that score high for&nbsp;attracting QSs.</p><p>Many investors mimic the portfolio of uber-QS Warren Buffett of Berkshire HathawayBRK.A,+0.12%BRK.B,+0.05%,for instance. Other QSs can be identified using such resources as Martijn Cremmers’&nbsp;active share rankings, proprietary data analytics of&nbsp;EQX, or research of my&nbsp;ownQuality Shareholders Initiative&nbsp;(QSI) — all useful tools to construct a&nbsp;high-performing portfolio.</p><p>Combining the&nbsp;Forgotten Forty&nbsp;with such data, below are three stock ideas to consider as part of a larger portfolio. (Of course, this is not investing advice or a recommendation to buy — just a few suggestions to consider.)</p><p><b>UniFirst Corporation</b></p><p>UniFirst Corp.UNF,+2.13%,founded by the Croatti family in a Boston barn in 1936, is a uniform rental company currently employing more than 14,000 in 260 facilities in North America and Europe and generating nearly $2 billion in annual revenue. It is number three in an oligopolistic industry — along with AramarkARMK,+0.27%and CintasCTAS,-0.37%,the trio commands 70% of the market — which enables rational industry pricing.</p><p>UniFirst’s core laundry business runs on multiyear contracts, creating recurring revenue. Customer retention rates are high and employee tenures are long, and the company carries no debt.&nbsp; Along with a strong cash position, the U.S. economic reopening ahead bodes well, particularly with UniFirst’s large customer base in the energy sector. Boyar’s valuation: $263 per share, well-above recent levels.</p><p>Members of the Croatti family are major shareholders, with 20% of the economic interest and 71% of the voting power, under a dual-class capital structure.&nbsp;Despite how some governance gurus roundly condemn dual class structures, QSI data indicates that&nbsp;QSs examine the practice&nbsp;on a case-by-case basis.</p><p>UniFirst is a magnet for QSs, increasingly so in recent years as the company has enhanced its capital allocation rationality through share buybacks and dividends. In terms of concentration levels and holding periods, the company’s shareholders treat it far better than they treat their other investees, EQX data indicates.&nbsp; A sampling of UniFirst’s QSs: Aurora Investment Counsel, Copeland Capital Management, Hunter Perkins Capital Management, London Company of Virginia and River Road Asset Management.</p><p><b>Comcast Corporation</b></p><p>ComcastCMCSA,+2.06%,a cable industry pioneer founded by Ralph Roberts in 1963, is a global communications powerhouse with diverse investments in related sectors, especially in technology. The business, with annual revenues exceeding $100 billion, proved resilient during the pandemic, with durable strengths in both broadband and streaming, and an expected bounce from reopening of its theme parks.</p><p>Communications businesses such as Comcast’s combine highly valuable intangible assets with little need for reinvestment in tangible assets—particularly appealing during inflationary periods. Boyar’s valuation: $76 per share, comfortably above market.</p><p>Comcast is another magnet for QSs, and another dual class company, in which Brian Roberts holds 1% of the economic interest along with 34% of the voting power. Among QSs owning Comcast shares: Eagle Capital, First Pacific Advisors, Rothschild &amp; Co. and Southeastern Asset Management. Note also: Nelson Peltz’s Trian Fund accumulated a large stake, about 0.4%, in several transactions during 2020.</p><p><b>Bank of New York Mellon</b></p><p>Bank of New York MellonBK,+0.86%is the world’s largest custodian bank and asset servicing company, with $2 trillion in assets under management and close to $40 trillion in assets under custody. The company is a blend of two storied institutions: Bank of New York has roots back to Alexander Hamilton and Aaron Burr in 1784, while Mellon traces to the bank Andrew Mellon began in 1869.</p><p>Today, with annual revenues reaching $16 billion, the firm is distinguished for achieving outsized cost savings from a high-tech digitized platform. It is using artificial intelligence and machine learning to automate many functions, from financial calculations to client inquiries. BNY Mellon’s scale in the custodian business positions it well to win the trillion-dollar accounts of the world’s largest asset managers.</p><p>Boyar’s valuation for BNY Mellon is a conservative $50 per share, suggesting there’s still some upside. BNY Mellon enjoys one of the highest-quality shareholder bases in the US, according to EQX and QSI research. Prominent QSs include: Berkshire Hathaway, Davis Selected Advisers, Dodge &amp; Cox, Lountzis Asset Management and Tweedy Browne.</p><p>Three picks do not a portfolio make, of course. So consider these other interesting ideas from the Boyar&nbsp;Forgotten Forty&nbsp;that also boast high-quality shareholder followings: Walt DisneyDIS,+0.17%,IAC/InterActiveCorp.IAC,+3.19%and MerckMRK,-0.35%.</p><p>In a volatile market like now, all of these companies offer a substantial measure of stability.&nbsp; For veteran investors and newcomers alike, keep in mind that it is foolish to follow the herd, and wise to heed the thoughtful.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: These cool, high-quality stocks are just right for this overheated, overvalued market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: These cool, high-quality stocks are just right for this overheated, overvalued market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-27 11:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/these-cool-high-quality-stocks-are-just-right-for-this-overheated-overvalued-market-11621994657><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Well-managed companies boast strong cash flow, a stable shareholder base, and are under most investors’ radar.Overheated markets make it increasingly difficult to identify attractively priced ...</p>\n\n<a href=\"https://www.marketwatch.com/story/these-cool-high-quality-stocks-are-just-right-for-this-overheated-overvalued-market-11621994657\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/these-cool-high-quality-stocks-are-just-right-for-this-overheated-overvalued-market-11621994657","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193634953","content_text":"Well-managed companies boast strong cash flow, a stable shareholder base, and are under most investors’ radar.Overheated markets make it increasingly difficult to identify attractively priced investments. But with hordes of buyers plunking capital onmeme stocks and cryptocurrencies,quality shareholders (aka buy-and-hold stock pickers) continue to see opportunities for the long term.Take Boyar Value Group. Since 1975, it has provided insightful research on a range of businesses. The father and son team of Mark and Jonathan Boyar also eat their own cooking, being quality shareholders (QSs) themselves as operators of the Boyar Value FundBOYAX,+0.48%.The Boyars have been prescient: shortly after the coronavirus pandemic hit and took down the U.S. stock market, they released a special report detailing 19 companies whose shares they recommended amid the selloff.  One year later, a portfolio of those stocks was up 78%, besting the S&P 500SPX,+0.19%by 27 percentage points.Boyar Value Group produces the “Forgotten Forty,” a year-end report on 40 stocks they view as overlooked.  Barron’s highlighted seven of the picks earlier this year — a diverse mix that included Bank of AmericaBAC,+0.07%,Liberty Braves GroupBATRA,+1.26%,and SyscoSYY,-0.52%.This year’s Forgotten Forty has gained 17% since late December versus 12% for the S&P 500.Boyar’s Forgotten Forty is an excellent filter for stock pickers as they narrow their hunt. One way to tailor picks is to cross-check these 40 companies with those of companies that score high for attracting QSs.Many investors mimic the portfolio of uber-QS Warren Buffett of Berkshire HathawayBRK.A,+0.12%BRK.B,+0.05%,for instance. Other QSs can be identified using such resources as Martijn Cremmers’ active share rankings, proprietary data analytics of EQX, or research of my ownQuality Shareholders Initiative (QSI) — all useful tools to construct a high-performing portfolio.Combining the Forgotten Forty with such data, below are three stock ideas to consider as part of a larger portfolio. (Of course, this is not investing advice or a recommendation to buy — just a few suggestions to consider.)UniFirst CorporationUniFirst Corp.UNF,+2.13%,founded by the Croatti family in a Boston barn in 1936, is a uniform rental company currently employing more than 14,000 in 260 facilities in North America and Europe and generating nearly $2 billion in annual revenue. It is number three in an oligopolistic industry — along with AramarkARMK,+0.27%and CintasCTAS,-0.37%,the trio commands 70% of the market — which enables rational industry pricing.UniFirst’s core laundry business runs on multiyear contracts, creating recurring revenue. Customer retention rates are high and employee tenures are long, and the company carries no debt.  Along with a strong cash position, the U.S. economic reopening ahead bodes well, particularly with UniFirst’s large customer base in the energy sector. Boyar’s valuation: $263 per share, well-above recent levels.Members of the Croatti family are major shareholders, with 20% of the economic interest and 71% of the voting power, under a dual-class capital structure. Despite how some governance gurus roundly condemn dual class structures, QSI data indicates that QSs examine the practice on a case-by-case basis.UniFirst is a magnet for QSs, increasingly so in recent years as the company has enhanced its capital allocation rationality through share buybacks and dividends. In terms of concentration levels and holding periods, the company’s shareholders treat it far better than they treat their other investees, EQX data indicates.  A sampling of UniFirst’s QSs: Aurora Investment Counsel, Copeland Capital Management, Hunter Perkins Capital Management, London Company of Virginia and River Road Asset Management.Comcast CorporationComcastCMCSA,+2.06%,a cable industry pioneer founded by Ralph Roberts in 1963, is a global communications powerhouse with diverse investments in related sectors, especially in technology. The business, with annual revenues exceeding $100 billion, proved resilient during the pandemic, with durable strengths in both broadband and streaming, and an expected bounce from reopening of its theme parks.Communications businesses such as Comcast’s combine highly valuable intangible assets with little need for reinvestment in tangible assets—particularly appealing during inflationary periods. Boyar’s valuation: $76 per share, comfortably above market.Comcast is another magnet for QSs, and another dual class company, in which Brian Roberts holds 1% of the economic interest along with 34% of the voting power. Among QSs owning Comcast shares: Eagle Capital, First Pacific Advisors, Rothschild & Co. and Southeastern Asset Management. Note also: Nelson Peltz’s Trian Fund accumulated a large stake, about 0.4%, in several transactions during 2020.Bank of New York MellonBank of New York MellonBK,+0.86%is the world’s largest custodian bank and asset servicing company, with $2 trillion in assets under management and close to $40 trillion in assets under custody. The company is a blend of two storied institutions: Bank of New York has roots back to Alexander Hamilton and Aaron Burr in 1784, while Mellon traces to the bank Andrew Mellon began in 1869.Today, with annual revenues reaching $16 billion, the firm is distinguished for achieving outsized cost savings from a high-tech digitized platform. It is using artificial intelligence and machine learning to automate many functions, from financial calculations to client inquiries. BNY Mellon’s scale in the custodian business positions it well to win the trillion-dollar accounts of the world’s largest asset managers.Boyar’s valuation for BNY Mellon is a conservative $50 per share, suggesting there’s still some upside. BNY Mellon enjoys one of the highest-quality shareholder bases in the US, according to EQX and QSI research. Prominent QSs include: Berkshire Hathaway, Davis Selected Advisers, Dodge & Cox, Lountzis Asset Management and Tweedy Browne.Three picks do not a portfolio make, of course. So consider these other interesting ideas from the Boyar Forgotten Forty that also boast high-quality shareholder followings: Walt DisneyDIS,+0.17%,IAC/InterActiveCorp.IAC,+3.19%and MerckMRK,-0.35%.In a volatile market like now, all of these companies offer a substantial measure of stability.  For veteran investors and newcomers alike, keep in mind that it is foolish to follow the herd, and wise to heed the thoughtful.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":1394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115169754,"gmtCreate":1622959557178,"gmtModify":1634096556867,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/115169754","repostId":"1102972710","repostType":4,"isVote":1,"tweetType":1,"viewCount":941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137735309,"gmtCreate":1622389345301,"gmtModify":1634101875427,"author":{"id":"3581817202947175","authorId":"3581817202947175","name":"priswong","avatar":"https://static.tigerbbs.com/1c6662d0fbf1d14d728f78d18e375a47","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581817202947175","idStr":"3581817202947175"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/137735309","repostId":"2138107131","repostType":4,"isVote":1,"tweetType":1,"viewCount":1173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}